Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemi...
Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial
About this item
Full title
Author / Creator
Bethell, Delia , Se, Youry , Lon, Chanthap , Tyner, Stuart , Saunders, David , Sriwichai, Sabaithip , Darapiseth, Sea , Teja-Isavadharm, Paktiya , Khemawoot, Phisit , Schaecher, Kurt , Ruttvisutinunt, Wiriya , Lin, Jessica , Kuntawungin, Worachet , Gosi, Panita , Timmermans, Ans , Smith, Bryan , Socheat, Duong and Fukuda, Mark M
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
The emergence of artemisinin resistance has raised concerns that the most potent antimalarial drug may be under threat. The currently recommended daily dose of artesunate (AS) is 4 mg/kg, and is administered for 3 days together with a partner antimalarial drug. This study investigated the impact of different AS doses on clinical and parasitological...
Alternative Titles
Full title
Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1294869754
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1294869754
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0019283
